Summary by Futu AI
Kingsway Biotechnology Co., Ltd. (“Kingsley Biotechnology”) announced on 12 April 2024 that the Company's Board of Directors has proposed amendments to the current Articles of Association and Articles of Association to meet the latest regulatory requirements and internal management purposes. THE AMENDMENTS INCLUDE THE EXPANSION OF PAPERLESS LISTING MECHANISMS, THE TRANSMISSION OF COMPANY COMMUNICATIONS ELECTRONICALLY, AND UPDATES TO THE LISTING RULES EFFECTIVE FROM 31 DECEMBER 2023. The amendment is subject to approval by a special resolution at the upcoming Annual General Meeting of Shareholders. The Company will send to shareholders a circular containing the amendment details, the Notice of the Annual General Meeting and the Nomination Form in due course.